Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
C2 Pharma
CAI
DPS Group
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
API
107 Articles Available
1
5
Can't find what you're looking for? Try our
advanced search
.
Taste Masking Formulations
Formulating Flexibility with ActiMask® Taste Masking
PAO-10-022-CL-05
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
PR-M09-22-06
New Facility
Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site
PR-M07-22-04
API
Small Molecule API Market Trends
PAO-06-022--NI-11
R&D
Olon Announces the Creation of a Major Center of Research and Development in Italy, That Will Give Rise to an Innovative Global R&D Model
PR-M05-22-10
Manufacturing
The Evolving Technology Supporting API Manufacturing
PAO-04-22-R250-76
Advanced Excipients
How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs
PAO-04-022-CL-07
Specialty Chemicals
Looking at the Future of U.S. API Manufacturing
PAO-04-22-R250-02
API
CPhI Worldwide, A Significant Expansion of APIs Pipeline for Olon Group
PR-M11-21-02
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
PAO-09-21-CL-05
Sustainability
Olon Presents Its New Sustainability Manifesto
PR-M09-21-01
Expansion
Olon Announces a New Highly Potent API Expansion in Its Rodano Site
PR-M06-21-030
API
Maintaining API Supply During a Pandemic
PAO-04-22-R221-25
Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs
PR-M03-21-008
Nitrosamine
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
PAO-02021-CL-05
Chemistry, Manufacturing, and Controls
Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization
PAO-01-21-CL-05
Process Development
Innovative Approach to Process Development
PAO-02-21-CL-02
Equipment
Reshoring a Nation’s API and Pharmaceutical Production
PAP-Q3-20-CL-015
Collaboration
Better Together: Collaborating to Simplify Complexities in Drug Development
PAP-Q3-20-CL-028
Small-Volume Manufacturing
Benefits of Integrated Small-Volume Manufacturing Capabilities
PAP-Q1-20-CL-008
Complex Manufacturing
Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs Through Process Engineering and Technological Innovation
PAP-Q1-20-CL-017
Quality
Impurity Identification in Small-Molecule APIs
PAO-01-20-CL-005
Collaborative Culture
Tech Transfer and Scale-Up for Custom APIs Driven by a Collaborative Culture
PAP-Q3-19-CL-001
Global Network
Applying an Established and Continuously Upgraded Global Network for CDMO Services
PAP-Q3-19-CL-002
1
5
»
